Rafael Blanco-Domínguez

6PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
CXCR3 signaling promotes Delta One T cell recruitment and antitumor efficacy in colorectal cancer.

|May 13, 2026
Regulatory T cells sabotage anti-tumor γδ T cells by creating IL-2-deficient environments.

|Feb 11, 2026
Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy.

Bruno Silva-Santos, Sofia Mensurado, Rafael Blanco-Domínguez

|Apr 16, 2025
Dual modulation of cytotoxic and checkpoint receptors tunes the efficacy of adoptive Delta One T cell therapy against colorectal cancer.

Rafael Blanco-Domínguez, Leandro Barros, Mariana Carreira

|Mar 04, 2024
CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.

Sofia Mensurado, Carolina Condeço, Diego Sánchez-Martínez

|Jan 09, 2023
The emerging roles of γδ T cells in cancer immunotherapy.

Sofia Mensurado, Rafael Blanco-Domínguez, Bruno Silva-Santos

Pageof 1

Frequent Collaborators

6 joint publications

Bruno Silva-Santos

4 joint publications

Sofia Mensurado

2 joint publications

Leandro Barros

1 joint publications

Carolina Condeço